USGS - science for a changing world

Environmental Health - Toxic Substances

Headlines

Book Chapter on Exposure Modeling and Monitoring of Human Pharmaceuticals in the Environment

USGS scientist using a long sampling device to collect a sample of liquid from a municipal wastewater holding pond in Colorado as part of the Source Characterization Study for Emerging Contaminants Project. The sample was analyzed for pharmaceuticals and other wastewater compounds.
USGS scientist using a long sampling device to collect a sample of liquid from a municipal wastewater holding pond in Colorado as part of the Source Characterization Study for Emerging Contaminants Project. The sample was analyzed for pharmaceuticals and other wastewater compounds.
(click image for a larger version)

U.S. Geological Survey (USGS) scientist Dana W. Kolpin has co-authored a chapter in "Human Pharmaceuticals: Assessing the Impacts on Aquatic Ecosystems." The chapter, entitled "Environmental Exposure Modeling and Monitoring of Human Pharmaceutical Concentrations in the Environment," provides information on:

  • The use of predictive tools, such as exposure risk assessment models, for estimating the occurrence of pharmaceuticals in the environment.
  • The implementation of monitoring programs and strategies for pharmaceuticals in the environment.
  • Methods to predict the environmental occurrence and concentrations of pharmaceuticals.
  • Case studies on the comparison of model predictions with monitoring data.
Resource managers conducting environmental risk assessments can use this information on predictive tools and monitoring strategies in their assessments.

Reference

More information

  • Emerging Contaminants in the Environment, USGS investigations on the fate and occurrence of pharmaceuticals and other emerging contaminants
  • Similar and Related Publications
    • Barber, L.B., Brown, G.K., and Zaugg, S.D., 2000, Potential endocrine disrupting organic chemicals in treated municipal wastewater and river water, Chapter 7, in Keith, L.H., Jones-Lepp, T.L., and Needham, L.L., eds., Analysis of Environmental Endocrine Disruptors, ACS Symposium Series 747: Washington, D.C., American Chemical Society, p. 97-123.
    • Focazio, M.J., Kolpin, D.W., and Furlong, E.T., 2004, Occurrence of human pharmaceuticals in water resources in the United States—A review, in Kummerer, K., ed., Pharmaceuticals in the environment—Sources, fate, effects, and risks: Berlin, Heidelberg, New York, Springer-Verlag, p. 91-106.
    • Meyer, M.T., 2004, Use and environmental occurrence of veterinary pharmaceuticals in the United States, in Kummerer, K., ed., Pharmaceuticals in the Environment: Sources, Fate, Effects, and Risks: Berlin, Heidelberg, New York, Springer-Verlag, p. 155-163.

Related Headlines

More Headlines

USGS Home Water Climate Change Science Systems Ecosystems Energy and Minerals Environmental Health Hazards

Accessibility FOIA Privacy Policies and Notices

Take Pride in America logo USA.gov logo U.S. Department of the Interior | U.S. Geological Survey
URL: http://toxics.usgs.gov/highlights/pharm_chapter.html
Page Contact Information:
Page Last Modified: Friday, 06-Jun-2014 16:58:51 EDT

Created on Wednesday, July 19, 2006